US equities
|
NVDA
$238.68
▲+2.02%
SPCX
$167.24
▲+5.21%
MU
$1,063.29
▼-1.08%
TSLA
$380.36
▲+2.64%
MSFT
$525.79
▲+1.60%
SNDK
$1,706.50
▼-0.78%
INTC
$117.25
▼-1.75%
META
$742.95
▲+2.04%
NVDA
$238.68
▲+2.02%
SPCX
$167.24
▲+5.21%
MU
$1,063.29
▼-1.08%
TSLA
$380.36
▲+2.64%
MSFT
$525.79
▲+1.60%
SNDK
$1,706.50
▼-0.78%
INTC
$117.25
▼-1.75%
META
$742.95
▲+2.04%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Blackstone Life Sciences
Blackstone Life Sciences Invests $250 Million in Anagram Therapeutics to Advance Novel and Patient-Friendly Oral Enzyme Replacement Therapy for Pancreatic Insufficiency
May 07, 2026
From
Blackstone Life Sciences
Via
Business Wire
Tickers
BX
Monika Vnuk and Matt Lane join Blackstone Life Sciences as Managing Directors
October 13, 2021
From
Blackstone Life Sciences
Via
Business Wire
Tickers
BX